Wider Approval for Cystic Fibrosis 'Miracle' Drug
The MHRA extended the licence for Kaftrio, a disease-modulating therapy for cystic fibrosis, to children under 12.
Source: medscape.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Changing Drug. Real-time updates on events, politics, business and more.